Althea Technologies, has signed a Letter of Intent to establish a complementary commercialization partnership with Protein'eXpert of Grenoble, France. The agreement provides access to Protein'eXpert's advanced protein engineering, process development and optimization expertise, along with the Althea's cGMP manufacturing resources for production and fill/finish services from Phase I clinical to commercial manufacturing.

"The partnership with Althea Technologies is a great opportunity for us. Their very strong position in the U.S. market and their outstanding production facilities shall perfectly complement our expertise and set of services based on Recombinant protein engineering, development and small scale cGMP production," says Dr. Tristan Rousselle, chief executive officer of Protein'eXpert.

"We are very pleased to enter this agreement with Protein'eXpert. Their highly regarded science and service standards are a wonderful complement to Althea's manufacturing services. We are confident that this will strengthen Althea's presence in Europe and provide Althea clients valuable early stage process development capabilities," stated Dr. Magda Marquet, president and co-chief executive officer of Althea Technologies.